- Home
- TUSK vs CTNM Comparison
TUSK vs CTNM Comparison
Compare TUSK & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TUSK
- CTNM
- Stock Information
- Founded
- TUSK 2014
- CTNM 2009
- Country
- TUSK United States
- CTNM United States
- Employees
- TUSK N/A
- CTNM N/A
- Industry
- TUSK Oilfield Services/Equipment
- CTNM
- Sector
- TUSK Energy
- CTNM
- Exchange
- TUSK Nasdaq
- CTNM Nasdaq
- Market Cap
- TUSK 128.0M
- CTNM 114.1M
- IPO Year
- TUSK 2016
- CTNM 2024
- Fundamental
- Price
- TUSK $2.67
- CTNM $4.43
- Analyst Decision
- TUSK
- CTNM Strong Buy
- Analyst Count
- TUSK 0
- CTNM 4
- Target Price
- TUSK N/A
- CTNM $22.50
- AVG Volume (30 Days)
- TUSK 138.6K
- CTNM 100.8K
- Earning Date
- TUSK 05-07-2025
- CTNM 05-14-2025
- Dividend Yield
- TUSK N/A
- CTNM N/A
- EPS Growth
- TUSK N/A
- CTNM N/A
- EPS
- TUSK N/A
- CTNM N/A
- Revenue
- TUSK $207,208,000.00
- CTNM N/A
- Revenue This Year
- TUSK N/A
- CTNM N/A
- Revenue Next Year
- TUSK $28.22
- CTNM N/A
- P/E Ratio
- TUSK N/A
- CTNM N/A
- Revenue Growth
- TUSK N/A
- CTNM N/A
- 52 Week Low
- TUSK $1.68
- CTNM $3.35
- 52 Week High
- TUSK $4.94
- CTNM $22.00
- Technical
- Relative Strength Index (RSI)
- TUSK 56.84
- CTNM N/A
- Support Level
- TUSK $2.59
- CTNM N/A
- Resistance Level
- TUSK $2.77
- CTNM N/A
- Average True Range (ATR)
- TUSK 0.15
- CTNM 0.00
- MACD
- TUSK 0.02
- CTNM 0.00
- Stochastic Oscillator
- TUSK 75.61
- CTNM 0.00
About TUSK Mammoth Energy Services Inc.
Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes well completion services (Well Completion), infrastructure services (Infrastructure) and natural sand proppant services (Sand). Key revenue is generated from Infrastructure which include electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities, etc.
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.